QT
KRON

Quantbot Technologies’s Kronos Bio KRON Stock Holding History

Quantbot Technologies’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,595
Closed -$3.79K – 1777
2023
Q1 		$3.79K Hold
2,595
– – ﹤0.01% 1452
2022
Q4 		$4.2K Sell
2,595
-1,500
-37% -$3.45K ﹤0.01% 1566
2022
Q3 		$13K Sell
4,095
-8,700
-68% -$39.3K ﹤0.01% 1401
2022
Q2 		$46K Buy
12,795
+6,100
+91% +$27.6K ﹤0.01% 1317
2022
Q1 		$48K Buy
6,695
+3,995
+148% +$34.1K ﹤0.01% 1199
2021
Q4 		$36K Buy
+2,700
New +$42.2K ﹤0.01% 1106

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quantbot Technologies's KRON Position: Q2 2023 in Review

Quantbot Technologies sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 2,595 shares — an estimated $3.79K sold.

Quantbot Technologies first reported a position in KRON in Q4 2021 and held it in 6 quarters. The position peaked at $48K in Q1 2022. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • Quantbot Technologies reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • Quantbot Technologies sold 2,595 Kronos Bio shares in Q2 2023, an estimated $3.79K.
  • Quantbot Technologies first reported a position in Kronos Bio in Q4 2021 and held it in 6 quarters.
  • Quantbot Technologies's Kronos Bio position peaked at $48K in Q1 2022.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on Quantbot Technologies's 13F filing for Q2 2023, filed 8 Aug 2023.